about
Risk factors for Pneumocystis jirovecii pneumonia (PJP) in kidney transplantation recipients.Sirolimus conversion efficacy for graft function improvement and histopathology in renal recipients with mild to moderate renal insufficiency.Impact of pretransplant rituximab induction on highly sensitized kidney recipients: comparison with non-rituximab group.Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis after Concurrent Chemoradiation Therapy.Illumina-microarray analysis of mycophenolic acid-induced cell death in an insulin-producing cell line and primary rat islet cells: new insights into apoptotic pathways involved.Impact of coculture with ischemic preconditioned hepatocellular carcinoma cell line (Hep-G2) cells on insulin secreting function of rat insulin-secreting cell line (RIN-5F) cells.Manufacturing of insulin-secreting spheroids with the RIN-5F cell line using a shaking culture method.Sirolimus-induced pneumonitis after renal transplantation: a single-center experience.Results of ABO-incompatible liver transplantation using a simplified protocol at a single institution.Comparison of the affinity column-mediated immunoassay and microparticle enzyme immunoassay methods as a tacrolimus concentration assay in the early period after liver transplantation.Predictors of kidney volume change and delayed kidney function recovery after donor nephrectomy.Risk factors and characteristics of post-transplant tuberculosis in an endemic area.Graft function measured by transient elastography in living donor liver transplantation: preliminary.Usefulness of Oxford classification in assessing immunoglobulin A nephropathy after transplantation.Normal controlled attenuation parameter values: a prospective study of healthy subjects undergoing health checkups and liver donors in Korea.Stevens-Johnson syndrome in a liver transplant recipient.Comparison of the tuberculin skin test and interferon-γ release assay for the diagnosis of latent tuberculosis infection before kidney transplantationOutcome of kidney allograft in patients with adulthood-onset focal segmental glomerulosclerosis: comparison with childhood-onset FSGSDevelopment of a Korean Liver Allocation System using Model for End Stage Liver Disease Scores: A Nationwide, Multicenter studyEfficacy of a negative conversion trial and subsequent living donor kidney transplant outcome in recipients with a positive lymphocyte crossmatchRenal replacement therapy: available information versus demands of patientsDoes lymphocyte cross-matching predict acute rejection and graft survival in liver transplantation?The effects of AEB071 (sotrastaurin) with tacrolimus on rat heterotopic cardiac allograft rejection and survivalGraft survival after video-assisted minilaparotomy living-donor nephrectomy or conventional open nephrectomy: do left and right allografts differ?First report of a living liver graft in combined lung and liver transplantationSustained perfusion of revascularized bioengineered livers heterotopically transplanted into immunosuppressed pigsAuthor Correction: Sustained perfusion of revascularized bioengineered livers heterotopically transplanted into immunosuppressed pigsFavourable outcome of pathologic downstaging by locoregional treatment for hepatocellular carcinoma in liver transplantation
P50
Q33685858-50A274B9-7BAB-44E5-82FD-60DC24A16E5CQ34029931-8634C8B7-FC60-4317-9861-E75FEBDA8EAEQ36028067-C5508AAF-804D-4C9F-8E7F-DF95C9E8CD31Q37124855-3D14BF53-699B-44A7-A2CA-3F2C668BCE11Q38342380-6EEDFAFA-9081-43A7-ABB1-B42B19AF6820Q39352503-290595EC-DA90-482C-B0F7-523810E02043Q39618435-BD4F72C7-0CA0-47A8-A2AA-988179E0E2B0Q40297055-08D244B0-7F7E-468C-9E6B-13D08513D2EBQ41310008-0683C94E-68D3-44BC-ACA3-1449D31976B3Q42776186-A413C683-C3C1-41BA-96FE-AFC2169109E6Q42965593-D9B72F0D-F670-4EB2-8524-08A2F87170E1Q45005588-32359732-FCB7-42F6-A4EC-FEE7C85D97E4Q45069484-6C9BA812-4F5F-46BD-96DC-9DC96CD4CA13Q45713191-C2BB1A1F-9192-4B1B-B154-73F6DA00EA14Q53265078-21E575F2-3874-41D5-B1DC-6BA3ADB7F1DAQ53518988-766C44E1-37C1-45E2-AA08-D99C099C536BQ57213861-C2A650F2-20E2-4786-A3EB-541C91F7A228Q57225290-7580F194-3A51-4FE8-A3AF-0CC0785EC4C7Q64262017-22EC2598-006D-4563-AF93-73D15122069DQ82818016-43775473-CD27-48F9-B6FC-086A28A032F3Q83396309-C4E5EE14-7D0B-4C3A-8F0F-101789A9BD84Q83627778-43BB08A3-9ECD-40AB-99F7-C73F5B4AD64AQ84683032-9EFDDA9B-1EF8-4223-8C2B-50FE6E65ADF8Q87657976-C60C34ED-E4F7-4177-9359-3DA7486B2DBAQ89451986-18528084-CF45-4224-A513-C46789E6668BQ90703996-79027F93-43C4-465B-8AB5-C7D38355D108Q91130399-24E4704B-E620-4C67-83AC-6973F559777FQ91968992-CD44F9CC-779D-4745-9F41-6E52337E6FF2
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Dong Jin Joo
@ast
Dong Jin Joo
@en
Dong Jin Joo
@es
Dong Jin Joo
@nl
Dong Jin Joo
@sl
type
label
Dong Jin Joo
@ast
Dong Jin Joo
@en
Dong Jin Joo
@es
Dong Jin Joo
@nl
Dong Jin Joo
@sl
prefLabel
Dong Jin Joo
@ast
Dong Jin Joo
@en
Dong Jin Joo
@es
Dong Jin Joo
@nl
Dong Jin Joo
@sl
P106
P1153
21834227300
P31
P496
0000-0001-8405-1531